You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/11/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 02/10/20 | SEC STAFF LETTER |
|
1 | ||
| 02/07/20 | 8-K | Current report filing |
|
48 | |
| 02/07/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
75 | |
| 02/07/20 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 02/06/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
75 | |
| 02/03/20 | SEC STAFF LETTER |
|
2 | ||
| 01/13/20 | 8-K | Current report filing |
|
42 | |
| 01/09/20 | 8-K | Current report filing |
|
11 | |
| 01/07/20 | 8-K | Current report filing |
|
6 |
